A sortable and searchable running inventory of global medtech regulatory and policy official documents, including rules, guidance documents, memos, white papers, and more from national authorities, non-governmental groups, and global organizations.
Welcome to MyStrategist
Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
Trial MyStrategist.com and unlock 7-days of exclusive subscriber-only access to MedTech Strategist & Market PathwaysStart Trial
The COVID-19 pandemic has had a profound impact on hospitals across APAC. Despite being able to control its spread initially, many countries in the region were hit with subsequent waves that are proving harder to manage. Hospital budgets have been affected, creating a new dynamic for medical device manufacturers. By Stephen Sunderland, Fabio La Mola, and Patrick Branch, L.E.K. Consulting.
Don't Just Advertise... Strategize!
Advertise with MedTech Strategist and be seen by medtech's most influential executives.Learn More
The Biden administration’s FY 2022 budget request includes some notable increases and reform proposals for FDA. Here are a few takeaways for medtech.